| 摘要 |
<p>The present invention relates to new voltage-gated heterotetrameric potassium channels comprising Kv2.1, Kv3.1, Kv5.1, Kv6.3, Kv10.1 or Kv11.1 potassium channel subunits and their direct or indirect uses for diagnosing, preventing and/or treating excitability disorders. Moreover, the present invention discloses the cDNA sequence of the Kv10.1 potassium channel subunit.</p> |
